CA-NETAPP
NetApp® (NASDAQ: NTAP), a global cloud-led, data centric software company, today announced they are targeting small and medium businesses with a new bundled virtualization solution that will be sold and marketed by Fujitsu, a VMware and NetApp reseller. The solution delivers an integrated and affordable virtualized infrastructure solution to help small and medium businesses simplify and accelerate the management of traditional and modern applications, sold and supported through Fujitsu and Fujitsu partners. It uses the latest VMware vSphere 8 virtualization software, Fujitsu PRIMERGY Servers, and NetApp all-flash storage systems, complete with NetApp ONTAP integration to vSphere.
According to a 2023 IDC European CloudOps survey, approximately 60 percent of organizations surveyed are spending two-to-three times more in the cloud than they had originally budgeted. As a result, many organizations today are taking an application-first, cloud-smart approach to how they build a hybrid and multicloud architecture and maintain flexibility and control of their virtual machines (VMs) and data.
“Small and midsize business require reliable technologies that can deliver enterprise-grade capabilities, but often find what’s available both complex and cost prohibitive,” said Jenni Flinders, Senior Vice President, WW Partner Organization at NetApp. “As we celebrate the 25th anniversary of our partnership with Fujitsu, we’re bringing a simplified and integrated virtualized infrastructure solution to the SMB market that delivers enterprise-class, hybrid multicloud architecture at an affordable price.”
The combination of the latest VMware vSphere virtualization software, Fujitsu PRIMERGY Servers, and NetApp All-Flash systems helps IT organizations deploy a cost-effective and efficient cloud-ready platform that is architected forward to seamlessly move workloads to public cloud providers of choice and bring workloads back on-premises if desired while maintaining operational consistency.
“At Fujitsu, we are committed to delivering innovative solutions to market that empower our customers, regardless of their size or industry,” said Christian Leutner, Vice President and Head of European Platform Business at Fujitsu. “Our collaboration with NetApp means we can now deliver simplified, cost-effective virtualization solutions to our customers, allowing us to focus on innovation and to gain competitive edge.”
Key benefits of this bundled solution include:
- VMware vSphere 8 enterprise virtualization software, which brings the benefits of cloud to on-premises deployments
- Fujitsu PRIMERGY Servers running the latest Intel x86 processors, Fujitsu Software Infrastructure Manager (SIM), and Fujitsu Professional Services
- NetApp all-flash A150 storage management arrays offering enterprise-class performance at entry-level price
- NetApp ONTAP data management software and API integrations to vSphere to simplify storage provisioning and operations
- NetApp Software Bundle, which includes NetApp technologies such as SnapCenter, SnapMirror, SnapRestore and FlexClone to offload and simplify data management operations
“We’ve all seen a strong shift from cloud-first to cloud-smart approaches as IT organizations seek solutions with the fastest ROI for the business,” says Ricky Cooper, Head Partner of WW Partner and Commercial Sales at VMware. “Together with Fujitsu and NetApp, we offer customers a world class and affordable hybrid cloud infrastructure for their customer workloads.”
NetApp, Fujitsu, and VMware are focused on helping customers simplify and standardize IT infrastructure and operations. The result for customers is an enterprise-class, virtualized, cloud-smart, and complete infrastructure with simplified procurement, services, and support, affordably priced for the midmarket.
The Fujitsu, NetApp, VMware Hybrid Cloud solution is available and sold through Fujitsu directly and through Fujitsu, NetApp, and VMware authorized channel partners.
About NetApp
NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software, and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services, and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
Additional Resources
NetApp VMware Solutions
NetApp AFF A150
NetApp ONTAP Data Management
Fujitsu Evad Case study
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231107801232/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom